Dabigatran after Short Heparin Anticoagulation for Acute Intermediate-Risk Pulmonary Embolism: Rationale and Design of the Single-Arm PEITHO-2 Study

Klok, F.A.; Ageno, W.; Barco, S.; Binder, H.; Brenner, B.; Duerschmied, D.; ... ; PEITHO-2 Investigators (2017)

Article / Letter to editor

• dabigatran
• pulmonary embolism
• intermediate risk
• venous thromboembolism recurrence
• right ventricular function
• major bleeding

• All authors: Klok, F.A.; Ageno, W.; Barco, S.; Binder, H.; Brenner, B.; Duerschmied, D.; Empen, K.; Faggiano, P.; Ficker, J.H.; Galie, N.; Ghuysen, A.; Held, M.; Heydenreich, N.; Huisman, M.V.; Jimenez, D.; Kozak, M.; Lang, I.M.; Lankeit, M.; Munzel, T.; Petris, A.; Pruszczyk, P.; Quitzau, K.; Schellong, S.; Schmidt, K.H.; Stefanovic, B.S.; Verschuren, F.; Wolf-Puetz, A.; Meyer, G.; Konstantinides, S.V.; PEITHO-2 Investigators
• Date: 2017-12-31
• Journal: Thrombosis and Haemostasis
• Volume: 117
• Issue: 12
• Pages: 2425 - 2434
• DOI: doi:10.1160/TH17-06-0434